StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Omnicell (OMCL) PT Lowered to $45 at Piper Sandler
August 3, 2026 8:15 AM
Piper Sandler analyst Jessica Tassan lowered the price target on Omnicell (NASDAQ:
OMCL
) to $45.00 (from $55.00) while maintaining a Overweight rating.
Categories
Analyst PT Change